TY - JOUR
T1 - Occupational lead exposure and survival with amyotrophic lateral sclerosis
AU - Wang, Te Wei
AU - Wuu, Joanne
AU - Cooley, Anne
AU - Yeh, Tian Shin
AU - Benatar, Michael
AU - Weisskopf, Marc
N1 - Publisher Copyright:
© 2022 World Federation of Neurology on behalf of the Research Group on Motor Neuron Diseases.
PY - 2022
Y1 - 2022
N2 - Objective: Lead exposure has been hypothesized to increase the risk of ALS, but only two studies have examined the association with ALS survival, and with inconsistent results. The use of occupational history to assess lead exposure can avoid reverse causation that may occur in epidemiologic analyses that use biomarkers of lead exposure collected after ALS onset. Methods: We evaluated the relationship of occupational lead exposure to ALS survival among 135 cases from an international ALS cohort that included deep phenotyping, careful follow-up, and questionnaires to quantify participants’ occupation history. ALS patients were recruited in 2015–2019. We determined occupational lead exposure using a job-exposure matrix. We estimated hazard ratios (HR) and 95% confidence intervals (CI) for survival using Cox proportional hazard analysis with adjustment for covariates. Results: A total of 135 ALS patients completed the environmental questionnaires, among whom 38 reached a survival endpoint (death or permanent assisted ventilation). The median survival was 48.3 months (25th–75th percentile, 30.9–74.1). Older patients and those with initial symptom other than limb onset had shorter survival time. There were 36 ALS cases with occupational lead exposure. After adjusting for age, sex, site of onset, smoking, and military service, lead exposure was associated with an HR of 3.26 (95%CI 1.28–8.28). Results with adjustment for subsets of these covariates were similar. Conclusions: These results suggest that lead exposure prior to onset of ALS is associated with shorter survival following onset of ALS, and this association is independent of other prognostic factors.
AB - Objective: Lead exposure has been hypothesized to increase the risk of ALS, but only two studies have examined the association with ALS survival, and with inconsistent results. The use of occupational history to assess lead exposure can avoid reverse causation that may occur in epidemiologic analyses that use biomarkers of lead exposure collected after ALS onset. Methods: We evaluated the relationship of occupational lead exposure to ALS survival among 135 cases from an international ALS cohort that included deep phenotyping, careful follow-up, and questionnaires to quantify participants’ occupation history. ALS patients were recruited in 2015–2019. We determined occupational lead exposure using a job-exposure matrix. We estimated hazard ratios (HR) and 95% confidence intervals (CI) for survival using Cox proportional hazard analysis with adjustment for covariates. Results: A total of 135 ALS patients completed the environmental questionnaires, among whom 38 reached a survival endpoint (death or permanent assisted ventilation). The median survival was 48.3 months (25th–75th percentile, 30.9–74.1). Older patients and those with initial symptom other than limb onset had shorter survival time. There were 36 ALS cases with occupational lead exposure. After adjusting for age, sex, site of onset, smoking, and military service, lead exposure was associated with an HR of 3.26 (95%CI 1.28–8.28). Results with adjustment for subsets of these covariates were similar. Conclusions: These results suggest that lead exposure prior to onset of ALS is associated with shorter survival following onset of ALS, and this association is independent of other prognostic factors.
KW - amyotrophic lateral sclerosis
KW - lead
KW - Occupation
KW - survival
UR - http://www.scopus.com/inward/record.url?scp=85129135958&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129135958&partnerID=8YFLogxK
U2 - 10.1080/21678421.2022.2059379
DO - 10.1080/21678421.2022.2059379
M3 - Article
C2 - 35400246
AN - SCOPUS:85129135958
SN - 2167-8421
VL - 24
SP - 100
EP - 107
JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
IS - 1-2
ER -